Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Hourigan

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Haematologica|December 1, 2022
The present and future of measurable residual disease testing in acute myeloid leukemiaJames S Blachly, Roland B Walter, Christopher S Hourigan
Blood|February 9, 2023
How I treat AML incorporating the updated classifications and guidelinesFiras El Chaer, Christopher S Hourigan, Amer M Zeidan
Leukemia|December 16, 2018
Refining AML outcome predictionChristopher S Hourigan, Robert Peter Gale, Roland B Walter
Journal of Leukemia (Los Angeles, Calif.)|September 23, 2014
Adult Acute Myeloid Leukemia Long-term SurvivorsM Jennifer Cheng, Christopher S Hourigan, Thomas J Smith
Best Practice & Research. Clinical Haematology|June 23, 2023
Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemiaZoë C Wong, Laura W Dillon, Christopher S Hourigan
Blood Reviews|February 14, 2017
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemiaMary-Elizabeth Percival, Catherine Lai, Elihu Estey, et al.
Expert Review of Hematology|June 24, 2017
Immunological effects of hypomethylating agentsKatherine E Lindblad, Meghali Goswami, Christopher S Hourigan, et al.
Seminars in Hematology|June 27, 2015
Advancing the Minimal Residual Disease Concept in Acute Myeloid LeukemiaPeter Hokland, Hans B Ommen, Matthew P Mulé, et al.
Bone Marrow Transplantation|November 1, 2019
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantationMegan Othus, Robert Peter Gale, Christopher S Hourigan, et al.
Journal of Clinical Medicine|September 20, 2017
Technical Advances in the Measurement of Residual Disease in Acute Myeloid LeukemiaGregory W Roloff, Catherine Lai, Christopher S Hourigan, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Haematologica|December 1, 2022
The present and future of measurable residual disease testing in acute myeloid leukemiaJames S Blachly, Roland B Walter, Christopher S Hourigan
Blood|February 9, 2023
How I treat AML incorporating the updated classifications and guidelinesFiras El Chaer, Christopher S Hourigan, Amer M Zeidan
Leukemia|December 16, 2018
Refining AML outcome predictionChristopher S Hourigan, Robert Peter Gale, Roland B Walter
Journal of Leukemia (Los Angeles, Calif.)|September 23, 2014
Adult Acute Myeloid Leukemia Long-term SurvivorsM Jennifer Cheng, Christopher S Hourigan, Thomas J Smith
Best Practice & Research. Clinical Haematology|June 23, 2023
Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemiaZoë C Wong, Laura W Dillon, Christopher S Hourigan
Blood Reviews|February 14, 2017
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemiaMary-Elizabeth Percival, Catherine Lai, Elihu Estey, et al.
Expert Review of Hematology|June 24, 2017
Immunological effects of hypomethylating agentsKatherine E Lindblad, Meghali Goswami, Christopher S Hourigan, et al.
Seminars in Hematology|June 27, 2015
Advancing the Minimal Residual Disease Concept in Acute Myeloid LeukemiaPeter Hokland, Hans B Ommen, Matthew P Mulé, et al.
Bone Marrow Transplantation|November 1, 2019
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantationMegan Othus, Robert Peter Gale, Christopher S Hourigan, et al.
Journal of Clinical Medicine|September 20, 2017
Technical Advances in the Measurement of Residual Disease in Acute Myeloid LeukemiaGregory W Roloff, Catherine Lai, Christopher S Hourigan, et al.
Pageof 15